| Home | E-Submission | Sitemap | Contact Us |  
J Neurocrit Care 2008;1(1): 12-21.
스트레스 단백질과 허혈성 내성
이종은
연세대학교 의과대학 해부학교실, 두뇌한국21 의과학사업단
Stress Proteins and Ischemic Tolerance
Jong Eun Lee, PhD
Department of Anatomy, BK21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
ABSTRACT
The phenomenon of ischemic tolerance (also referred to as ischemic preconditioning) is associated with the upregulation of a variety of genes and their proteins. One of highly upregulated proteins is the heat shock proteins (HSPs), which can be induced by exposure to an array of stresses including hyperthermia, excitotoxins, heavy metals, and pharmacologic agents, as well as ischemia. The major eukaryotic HSPs form a super-family consisting of several ubfamilies. Subfamilies are identified by molecular weight, which ranges from 10-170 kD, and are further sub-divided according to cellular localization, expression pattern, and function. They function as molecular chaperones, helping polypeptides assume their proper conformation by binding to nascent proteins via their C terminal domain. HSPs are also involved in antigen presentation, steroid receptor function, intracellular trafficking, nuclear receptor binding, and apoptosis. HSPs are increased following cerebral ischemic insults. While HSPs involved in direct protection of brain cells and other cells from arious stresses, it may not be required in the phenomenon of ischemic tolerance. It is likely that the cell protects itself through multiple echanisms depends on the nature of the tolerizing stress. Regardless, the exercise of isolating and characterizing upregulated genes in these experimental scenarios has led to the identification of a cytoprotective protein that may someday be applied at the clinical level.
Key Words: Stress proteins·Heat shock proteins·Ischemic tolerance·Preconditioning
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Share:      
METRICS
1,849
View
34
Download
Sepsis and Septic Shock  2010 May;3(Suppl 1)
Editorial Office
Department of Neurology and Critical Care, Seoul National University Hospital,
101, Daehak-ro, Jongno-gu, Seoul, 03080 Korea
TEL: +82-2-2072-0743 (10:00 AM ~ 4:00 PM) / +82-2-2072-1810   FAX: +82-2-3672-7553    E-mail: office@e-jnc.org

Copyright© Korean Neurocritical Care Society.                Developed in M2PI